ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Crystal-induced arthritis"

  • Abstract Number: 0048 • ACR Convergence 2023

    Monosodium Urate Crystals Activate an Immune Tolerance Program That Restrains the Activation of Inflammatory Signaling in Macrophages During Gout Flares

    Mohnish Alishala1, Stephen Calderon1, Anyan Chen1, Monica Guma2, Christopher glass1 and Isidoro Cobo1, 1University of California San Diego, San Diego, CA, 2University of California San Diego, La Jolla, CA

    Background/Purpose: Gout is the most frequent form of inflammatory arthritis, with episodes of self-resolving acute inflammation in the joint caused by the deposition of monosodium…
  • Abstract Number: 0246 • ACR Convergence 2023

    Safety & Efficacy of SEL-212 in Patients with Gout Refractory to Conventional Treatment: Primary Outcomes from Two Randomized, Double Blind, Placebo-Controlled, Multicenter Phase 3 Studies

    Herbert Baraf1, Alan Kivitz2, Sheri Rhodes3, Sheldon Leung4, Olu Folarin4, Tania Gonzalez-Rivera5, Joanna Sobierska5, Jacquie Christie5, Anand Patel6, Wesley DeHaan4, Rehan Azeem4 and Peter Traber7, 1The Center for Rheumatology and Bone Research, George Washington University, Rheumatology, Bethesda, MD, 2Altoona Center for Clinical Research, Duncansville, PA, 3Selecta Biosciences, Atlanta, GA, 4Selecta Biosciences, Inc., Watertown, MA, 5Swedish Orphan Biovitrum (Sobi), Stockholm, Sweden, 6Pioneer Research Solutions, Houston, TX, 7Selecta Biosciences, Gladwyne, PA

    Background/Purpose: In patients with refractory gout, the inability to maintain serum uric acid (sUA) levels < 6 mg/dL leads to severe clinical manifestations for which…
  • Abstract Number: 1145 • ACR Convergence 2022

    The Prostate Plays a Role in Serum Urate Levels and the Risk of Gout in Men

    Mariana Urquiaga1, Megan Leask1, Nicholas Sumpter1, Brooke Maxwell2, Sara Lewis2, Eric E. Kelley2 and Tony Merriman3, 1University of Alabama at Birmingham, Birmingham, AL, 2West Virginia University, Morgantown, WV, 3University of Otago, Dunedin, New Zealand

    Background/Purpose: Men have higher serum urate (SU) and increased prevalence of gout compared to pre-menopausal women. Xanthine oxidoreductase (XOR), encoded by the XDH gene, is…
  • Abstract Number: 1791 • ACR Convergence 2022

    Point-of-Care Multi-Energy Photon-Counting CT for Earlier Non-Invasive Diagnosis of Gout and Calcium Pyrophosphate Deposition Disease

    Fabio Becce1, Anais Viry2, Damien Racine2, David Rotzinger1, Tristan Pascart3, Georgios Filippou4, Jérôme Damet2 and Lucia Gallego Manzano2, 1Lausanne University Hospital (CHUV), Lausanne, Switzerland, 2Institute of Radiation Physics, Lausanne, Switzerland, 3Groupement Hospitalier de l'Institut Catholique de Lille, Lomme, France, 4Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

    Background/Purpose: While the definitive diagnosis of gout and calcium pyrophosphate deposition disease (CPPD) is still based on the identification of characteristic crystals in synovial fluid…
  • Abstract Number: 1801 • ACR Convergence 2022

    High Frequency of Structural Damage in the Lower Spine of Patients with Chondrocalcinosis

    Kalliopi Klavdianou1, Jona Kasfeld2, Martin Fruth3, Styliani Tsiami4, Juergen Braun5, Philipp Sewerin6, David Kiefer5 and Xenofon Baraliakos7, 1'Asklepieion' General Hospital, Department of Rheumatology, Voula, Athens, Greece, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Blikk, Radiologie, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany, 6Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 7Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Calcium pyrophosphate dihydrate crystal deposition disease (CPPD, chondrocalcinosis) is known to affect fibrocartilaginous tissue in the large and smaller peripheral joints. The affection of…
  • Abstract Number: 1804 • ACR Convergence 2022

    Raman Spectroscopy Integrated with Polarized Light Microscopy for Diagnosis of Crystallopathies

    Tom Niessink1, Matthijs Janssen2, Cees Otto1 and Tim Jansen3, 1Medical Cell Biophysics group, University of Twente, Enschede, Netherlands, 2Rijnstate Hospital, Bennekom, Netherlands, 3Department of Rheumatology, VieCuri Medical Centre, Venlo, Netherlands

    Background/Purpose: The current golden standard in diagnosing gout and calcium pyrophosphate deposition is polarized light microscopy (PLM). However, small crystal sizes, the presence of other…
  • Abstract Number: 1813 • ACR Convergence 2022

    Patient-Reported Outcomes in CPPD Compared to Gout and Osteoarthritis

    Mary Grace Whelan1, Keigo Hayashi2 and Sara Tedeschi1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Okayama, Japan

    Background/Purpose: Calcium pyrophosphate deposition (CPPD) disease prevalence is similar to gout and osteoarthritis (OA), yet CPPD outcomes research greatly lags behind these other forms of…
  • Abstract Number: 1817 • ACR Convergence 2022

    Acute Coronary Syndrome in Calcium Pyrophosphate Deposition Disease Patients: A Cross-sectional Study from the National Inpatient Sample

    Konstantinos Parperis1 and Bikash Bhattarai2, 1University of Cyprus Medical School, Nicosia, Cyprus, 2Valleywise Health, Phoenix, AZ

    Background/Purpose: Calcium pyrophosphate deposition disease (CPPD) is a common crystal-induced arthritis characterized by the deposition of calcium pyrophosphate crystals in the articular tissues. Acute CPP…
  • Abstract Number: 1825 • ACR Convergence 2022

    Vascular Calcifications Adjacent to the Involved Joint of Patients Diagnosed with Calcium Pyrophosphate Crystal Arthritis – a Retrospective Observational Study

    Shay Brikman1, Amir Bieber2 and Reuven Mader1, 1Rheumatic Diseases Unit, Emek Medical Center, Afula, Israel, 2Emek Medical Center, Raanana, Israel

    Background/Purpose: Prior studies have shown an association between chondrocalcinosis (CC) and vascular calcifications. In this study, we aimed to assess the presence of vascular calcifications…
  • Abstract Number: 1900 • ACR Convergence 2022

    CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK)-A Double-blind, Placebo-controlled Trial

    Jonathan Samuels1, Michael Pillinger2, Michael Toprover3, Svetlana Krasnokutsky Samuels4, Apoorva Patil5, Fernando Bomfim6, Renata La Rocca Vieira6, David Wei5, Sydney Catron5, Maryfe coronel5, Annie Kim5 and Sarah Moussavi5, 1NYU Langone, Rye Brook, NY, 2NYU Grossman School of Medicine, New York, NY, 3Division of Rheumatology, New York University Grossman School of Medicine and Rheumatology Section, New York Harbor Health Care System, New York Campus of the U.S. Department of Veterans Affairs, New York, NY, 4Westmed, Rye Brook, NY, 5NYU Langone Health, New York, NY, 6NYU Langone, New York, NY

    Background/Purpose: Knee osteoarthritis (OA) is an inflammatory disease, with a probable role for IL-1b. Calcium and urate crystals may promote OA by activating the NLRP3…
  • Abstract Number: 2208 • ACR Convergence 2022

    Diagnostic Performance of Hip Ultrasound in Calcium Pyrophosphate Deposition Disease

    Carina Soto-Fajardo1, Fabian Carranza-Enriquez2, Sinthia Solorzano Flores2, Abish Angeles2, Paola Flores2, Raul Pichardo-Bahena2, Luis Javier Jara Quezada2, Angélica Peña Ayala2, Victor-Manuel Ilizaliturri-Sanchez2, Georgios Filippou3 and Carlos Pineda2, 1Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 2Instituto Nacional de Rehabilitacion, Ciudad de México, Mexico, 3Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

    Background/Purpose: Calcium Pyrophosphate Deposition Disease (CPPD) is a chronic and potentially incapacitating disease. The reference standard for its diagnosis is the identification of calcium pyrophosphate…
  • Abstract Number: 1566 • ACR Convergence 2021

    Hyperuricemia Is Associated with Vascular Endothelial Dysfunction – the Impact of Hyperuricemia on Flow Mediated and Nitroglycerin Mediated Dilatation of the Brachial Artery

    Rachael Flood, Colm Kirby, David Kane and Ronan Mullan, Tallaght University Hospital, Dublin, Ireland

    Background/Purpose: Vascular endothelial cells line the entire circulatory system, these cells have very distinct and unique functions that are paramount to vascular biology. Hyperuricemia has…
  • Abstract Number: 1571 • ACR Convergence 2021

    Elevated Lactate, Procalcitonin Levels and SIRS (Systemic Inflammatory Response Syndrome) in a Subset of Patients with Gout

    Christopher Podgorski1, Paula Skarda2 and Elie Gertner3, 1Department of Medicine, University of Minnesota Medical School, Saint Paul, MN, 2Department of Medicine, Regions Hospital, University of Minnesota Medical School, Saint Paul, MN, 3Section of Rheumatology, Regions Hospital and Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN

    Background/Purpose: The intense inflammatory cascade of acute gouty inflammation makes it difficult to differentiate clinically between acute gouty inflammation and sepsis, particularly since they can…
  • Abstract Number: 1574 • ACR Convergence 2021

    Comparison of Urate Quantification in Gout and Asymptomatic Hyperuricemia by Ultrasound and Dual Energy Computed Tomography

    Rachael Flood1, Aamir Saeed2, Kate Harrington1, Conor Shortt1, Ronan Mullan1 and David Kane1, 1Tallaght University Hospital, Dublin, Ireland, 2Worcestershire Acute Hospitals NHS Trust., Worcester, United Kingdom

    Background/Purpose: The diagnostic gold standard for gout remains aspiration and identification of monosodium urate (MSU) crystals under polarised light microscopy. Joint aspiration is invasive and…
  • Abstract Number: 1580 • ACR Convergence 2021

    Whole Blood Gene Expression and eQTL Analysis Implicate GGT7 and FADS2 in Gout Pathogenesis

    Richard Reynolds1, Riku Takei1, Jeffrey Edberg1, Nicholas Sumpter1, Tony Merriman2 and Megan Leask1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Dunedin, New Zealand

    Background/Purpose: Gene expression studies of whole blood represent a powerful approach for understanding the pathogenesis of gout because differentially expressed transcripts may reflect the activation…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology